Hong Kong’s ban on cannabidiol (CBD) comes into effect on February 1, imposing harsh penalties for importing, producing, or possessing the substance.
CBD will be subject to the same strict controls as other drugs listed under the Dangerous Drugs Ordinance (DDO).
The importation of goods containing the component, including food and beverages, is forbidden, according to Hong Kong's customs administration, unless pertinent DDO rules are followed.
Au-Yeung Ka-lun, a customs intelligence officer, stated that CBD will be treated as a dangerous narcotic and will be governed by the Dangerous Drugs Ordinance.
The maximum punishment for importing, exporting, and producing CBD is a HKD 5 million fine and a life sentence. The maximum penalty for possession is seven years in prison and a fine of up to HKD 1 million.
By the end of the month, all items containing the component were to be put in trash boxes erected throughout the city, according to a government directive. Approximately 77,400 CBD-containing products, including dietary supplements and edible oils, have been gathered as of January 29.


Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Federal Reserve Faces Subpoena Delay Amid Investigation Into Chair Jerome Powell
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 



